Clinical Trial Update: Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma [NA]

View source ↗

Summary

Clinical trial evaluating testosterone gel to prevent weakness from steroid therapy in men with glioma was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Musculoskeletal Complications

Drugs mentioned

• Testosterone gel (Testosterone)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors, Musculoskeletal Complications | NA | Status: TERMINATED | Results posted: 2018-08-27